On Tuesday, NewAmsterdam Pharma Company NV (NASDAQ: NAMS) was -3.70% drop from the session before settling in for the closing price of $24.58. A 52-week
NewAmsterdam Pharma Company NV (NASDAQ: NAMS) kicked off on Tuesday, up 7.69% from the previous trading day, before settling in for the closing price of
A new trading day began on Tuesday, with NewAmsterdam Pharma Company NV (NASDAQ: NAMS) stock price up 41.41% from the previous day of trading, before
NewAmsterdam Pharma Company NV (NASDAQ: NAMS) open the trading on Wednesday, with a bit cautious approach as it glided -8.56% to $18.27, before settling in
On Monday, NewAmsterdam Pharma Company NV (NASDAQ: NAMS) was 4.21% up from the session before settling in for the closing price of $20.20. A 52-week
On Tuesday, NewAmsterdam Pharma Company NV (NASDAQ: NAMS) was -3.97% drop from the session before settling in for the closing price of $24.66. A 52-week
NewAmsterdam Pharma Company NV (NASDAQ: NAMS) established initial surge of 13.73% at $21.78, before settling in for the price of $19.15 at the close. Taking
NewAmsterdam Pharma Company NV (NASDAQ: NAMS) on Friday, soared 4.70% from the previous trading day, before settling in for the closing price of $17.02. Within
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.
